1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Drug Class
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
o 4.1 Global antiemetic drug market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global antiemetic drug market 2017 – 2021 ($ million)
o 4.2 Drug Class Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Drug Class Segment 2017 – 2021 ($ million)
o 4.3 Application Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Application Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
6 Market Segmentation by Drug Class
o 6.1 Market segments
o Exhibit 30: Chart on Drug Class – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Drug Class – Market share 2022-2027 (%)
o 6.2 Comparison by Drug Class
o Exhibit 32: Chart on Comparison by Drug Class
o Exhibit 33: Data Table on Comparison by Drug Class
o 6.3 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist – Market size and forecast 2022-2027
o Exhibit 34: Chart on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist – Year-over-year growth 2022-2027 (%)
o 6.4 Dopamine antagonist – Market size and forecast 2022-2027
o Exhibit 38: Chart on Dopamine antagonist – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Dopamine antagonist – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Dopamine antagonist – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Dopamine antagonist – Year-over-year growth 2022-2027 (%)
o 6.5 Neurokinin-1 (NK 1) receptor antagonist – Market size and forecast 2022-2027
o Exhibit 42: Chart on Neurokinin-1 (NK 1) receptor antagonist – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Neurokinin-1 (NK 1) receptor antagonist – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Neurokinin-1 (NK 1) receptor antagonist – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Neurokinin-1 (NK 1) receptor antagonist – Year-over-year growth 2022-2027 (%)
o 6.6 Cannabinoid receptor antagonist – Market size and forecast 2022-2027
o Exhibit 46: Chart on Cannabinoid receptor antagonist – Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Cannabinoid receptor antagonist – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Cannabinoid receptor antagonist – Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Cannabinoid receptor antagonist – Year-over-year growth 2022-2027 (%)
o 6.7 Others – Market size and forecast 2022-2027
o Exhibit 50: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 51: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by Drug Class
o Exhibit 54: Market opportunity by Drug Class ($ million)
o Exhibit 55: Data Table on Market opportunity by Drug Class ($ million)
7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 56: Chart on Application – Market share 2022-2027 (%)
o Exhibit 57: Data Table on Application – Market share 2022-2027 (%)
o 7.2 Comparison by Application
o Exhibit 58: Chart on Comparison by Application
o Exhibit 59: Data Table on Comparison by Application
o 7.3 Chemotherapy – Market size and forecast 2022-2027
o Exhibit 60: Chart on Chemotherapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Chemotherapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Chemotherapy – Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Chemotherapy – Year-over-year growth 2022-2027 (%)
o 7.4 Surgery – Market size and forecast 2022-2027
o Exhibit 64: Chart on Surgery – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Data Table on Surgery – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Chart on Surgery – Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Surgery – Year-over-year growth 2022-2027 (%)
o 7.5 Gastroenteritis – Market size and forecast 2022-2027
o Exhibit 68: Chart on Gastroenteritis – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Data Table on Gastroenteritis – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Chart on Gastroenteritis – Year-over-year growth 2022-2027 (%)
o Exhibit 71: Data Table on Gastroenteritis – Year-over-year growth 2022-2027 (%)
o 7.6 Others – Market size and forecast 2022-2027
o Exhibit 72: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 75: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by Application
o Exhibit 76: Market opportunity by Application ($ million)
o Exhibit 77: Data Table on Market opportunity by Application ($ million)
8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 79: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 80: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 81: Chart on Geographic comparison
o Exhibit 82: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 83: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 87: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 91: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 95: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 99: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 China – Market size and forecast 2022-2027
o Exhibit 103: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 107: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 108: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 109: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 Japan – Market size and forecast 2022-2027
o Exhibit 111: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 112: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 113: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 114: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.11 UK – Market size and forecast 2022-2027
o Exhibit 115: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 116: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 117: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 118: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 119: Market opportunity By Geographical Landscape ($ million)
o Exhibit 120: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 121: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 122: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 123: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 124: Impact of key risks on business
12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 125: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 126: Matrix on vendor position and classification
o 12.3 Boehringer Ingelheim International GmbH
o Exhibit 127: Boehringer Ingelheim International GmbH – Overview
o Exhibit 128: Boehringer Ingelheim International GmbH – Business segments
o Exhibit 129: Boehringer Ingelheim International GmbH – Key news
o Exhibit 130: Boehringer Ingelheim International GmbH – Key offerings
o Exhibit 131: Boehringer Ingelheim International GmbH – Segment focus
o 12.4 Cadila Pharmaceuticals Ltd.
o Exhibit 132: Cadila Pharmaceuticals Ltd. – Overview
o Exhibit 133: Cadila Pharmaceuticals Ltd. – Product / Service
o Exhibit 134: Cadila Pharmaceuticals Ltd. – Key offerings
o 12.5 Cipla Ltd.
o Exhibit 135: Cipla Ltd. – Overview
o Exhibit 136: Cipla Ltd. – Business segments
o Exhibit 137: Cipla Ltd. – Key news
o Exhibit 138: Cipla Ltd. – Key offerings
o Exhibit 139: Cipla Ltd. – Segment focus
o 12.6 Fresenius SE and Co. KGaA
o Exhibit 140: Fresenius SE and Co. KGaA – Overview
o Exhibit 141: Fresenius SE and Co. KGaA – Business segments
o Exhibit 142: Fresenius SE and Co. KGaA – Key news
o Exhibit 143: Fresenius SE and Co. KGaA – Key offerings
o Exhibit 144: Fresenius SE and Co. KGaA – Segment focus
o 12.7 GlaxoSmithKline Plc
o Exhibit 145: GlaxoSmithKline Plc – Overview
o Exhibit 146: GlaxoSmithKline Plc – Business segments
o Exhibit 147: GlaxoSmithKline Plc – Key news
o Exhibit 148: GlaxoSmithKline Plc – Key offerings
o Exhibit 149: GlaxoSmithKline Plc – Segment focus
o 12.8 Helsinn Healthcare SA
o Exhibit 150: Helsinn Healthcare SA – Overview
o Exhibit 151: Helsinn Healthcare SA – Product / Service
o Exhibit 152: Helsinn Healthcare SA – Key offerings
o 12.9 Lupin Ltd.
o Exhibit 153: Lupin Ltd. – Overview
o Exhibit 154: Lupin Ltd. – Product / Service
o Exhibit 155: Lupin Ltd. – Key news
o Exhibit 156: Lupin Ltd. – Key offerings
o 12.10 Merck and Co. Inc.
o Exhibit 157: Merck and Co. Inc. – Overview
o Exhibit 158: Merck and Co. Inc. – Business segments
o Exhibit 159: Merck and Co. Inc. – Key news
o Exhibit 160: Merck and Co. Inc. – Key offerings
o Exhibit 161: Merck and Co. Inc. – Segment focus
o 12.11 Novartis AG
o Exhibit 162: Novartis AG – Overview
o Exhibit 163: Novartis AG – Business segments
o Exhibit 164: Novartis AG – Key offerings
o Exhibit 165: Novartis AG – Segment focus
o 12.12 Otsuka Holdings Co. Ltd.
o Exhibit 166: Otsuka Holdings Co. Ltd. – Overview
o Exhibit 167: Otsuka Holdings Co. Ltd. – Business segments
o Exhibit 168: Otsuka Holdings Co. Ltd. – Key offerings
o Exhibit 169: Otsuka Holdings Co. Ltd. – Segment focus
o 12.13 Pfizer Inc.
o Exhibit 170: Pfizer Inc. – Overview
o Exhibit 171: Pfizer Inc. – Product / Service
o Exhibit 172: Pfizer Inc. – Key news
o Exhibit 173: Pfizer Inc. – Key offerings
o 12.14 Sanofi
o Exhibit 174: Sanofi – Overview
o Exhibit 175: Sanofi – Business segments
o Exhibit 176: Sanofi – Key news
o Exhibit 177: Sanofi – Key offerings
o Exhibit 178: Sanofi – Segment focus
o 12.15 Takeda Pharmaceutical Co. Ltd.
o Exhibit 179: Takeda Pharmaceutical Co. Ltd. – Overview
o Exhibit 180: Takeda Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 181: Takeda Pharmaceutical Co. Ltd. – Key news
o Exhibit 182: Takeda Pharmaceutical Co. Ltd. – Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 183: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 184: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 185: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 186: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 187: Teva Pharmaceutical Industries Ltd. – Segment focus
o 12.17 Viatris Inc.
o Exhibit 188: Viatris Inc. – Overview
o Exhibit 189: Viatris Inc. – Business segments
o Exhibit 190: Viatris Inc. – Key news
o Exhibit 191: Viatris Inc. – Key offerings
o Exhibit 192: Viatris Inc. – Segment focus
13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 193: Inclusions checklist
o Exhibit 194: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 195: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 196: Research methodology
o Exhibit 197: Validation techniques employed for market sizing
o Exhibit 198: Information sources
o 13.5 List of abbreviations
o Exhibit 199: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Drug Class
Exhibits6: Executive Summary – Chart on Market Segmentation by Application
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global antiemetic drug market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Drug Class Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Application Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Drug Class – Market share 2022-2027 (%)
Exhibits31: Data Table on Drug Class – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Drug Class
Exhibits33: Data Table on Comparison by Drug Class
Exhibits34: Chart on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Dopamine antagonist – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Dopamine antagonist – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Dopamine antagonist – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Dopamine antagonist – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Neurokinin-1 (NK 1) receptor antagonist – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Neurokinin-1 (NK 1) receptor antagonist – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Neurokinin-1 (NK 1) receptor antagonist – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Neurokinin-1 (NK 1) receptor antagonist – Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Cannabinoid receptor antagonist – Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Cannabinoid receptor antagonist – Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Cannabinoid receptor antagonist – Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Cannabinoid receptor antagonist – Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits51: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits52: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Drug Class ($ million)
Exhibits55: Data Table on Market opportunity by Drug Class ($ million)
Exhibits56: Chart on Application – Market share 2022-2027 (%)
Exhibits57: Data Table on Application – Market share 2022-2027 (%)
Exhibits58: Chart on Comparison by Application
Exhibits59: Data Table on Comparison by Application
Exhibits60: Chart on Chemotherapy – Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Chemotherapy – Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Chemotherapy – Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Chemotherapy – Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Surgery – Market size and forecast 2022-2027 ($ million)
Exhibits65: Data Table on Surgery – Market size and forecast 2022-2027 ($ million)
Exhibits66: Chart on Surgery – Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Surgery – Year-over-year growth 2022-2027 (%)
Exhibits68: Chart on Gastroenteritis – Market size and forecast 2022-2027 ($ million)
Exhibits69: Data Table on Gastroenteritis – Market size and forecast 2022-2027 ($ million)
Exhibits70: Chart on Gastroenteritis – Year-over-year growth 2022-2027 (%)
Exhibits71: Data Table on Gastroenteritis – Year-over-year growth 2022-2027 (%)
Exhibits72: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits73: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits74: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits75: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits76: Market opportunity by Application ($ million)
Exhibits77: Data Table on Market opportunity by Application ($ million)
Exhibits78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits79: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits80: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits81: Chart on Geographic comparison
Exhibits82: Data Table on Geographic comparison
Exhibits83: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits108: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits109: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits111: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits112: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits113: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits114: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits115: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits116: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits117: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits118: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits119: Market opportunity By Geographical Landscape ($ million)
Exhibits120: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits121: Impact of drivers and challenges in 2022 and 2027
Exhibits122: Overview on Criticality of inputs and Factors of differentiation
Exhibits123: Overview on factors of disruption
Exhibits124: Impact of key risks on business
Exhibits125: Vendors covered
Exhibits126: Matrix on vendor position and classification
Exhibits127: Boehringer Ingelheim International GmbH – Overview
Exhibits128: Boehringer Ingelheim International GmbH – Business segments
Exhibits129: Boehringer Ingelheim International GmbH – Key news
Exhibits130: Boehringer Ingelheim International GmbH – Key offerings
Exhibits131: Boehringer Ingelheim International GmbH – Segment focus
Exhibits132: Cadila Pharmaceuticals Ltd. – Overview
Exhibits133: Cadila Pharmaceuticals Ltd. – Product / Service
Exhibits134: Cadila Pharmaceuticals Ltd. – Key offerings
Exhibits135: Cipla Ltd. – Overview
Exhibits136: Cipla Ltd. – Business segments
Exhibits137: Cipla Ltd. – Key news
Exhibits138: Cipla Ltd. – Key offerings
Exhibits139: Cipla Ltd. – Segment focus
Exhibits140: Fresenius SE and Co. KGaA – Overview
Exhibits141: Fresenius SE and Co. KGaA – Business segments
Exhibits142: Fresenius SE and Co. KGaA – Key news
Exhibits143: Fresenius SE and Co. KGaA – Key offerings
Exhibits144: Fresenius SE and Co. KGaA – Segment focus
Exhibits145: GlaxoSmithKline Plc – Overview
Exhibits146: GlaxoSmithKline Plc – Business segments
Exhibits147: GlaxoSmithKline Plc – Key news
Exhibits148: GlaxoSmithKline Plc – Key offerings
Exhibits149: GlaxoSmithKline Plc – Segment focus
Exhibits150: Helsinn Healthcare SA – Overview
Exhibits151: Helsinn Healthcare SA – Product / Service
Exhibits152: Helsinn Healthcare SA – Key offerings
Exhibits153: Lupin Ltd. – Overview
Exhibits154: Lupin Ltd. – Product / Service
Exhibits155: Lupin Ltd. – Key news
Exhibits156: Lupin Ltd. – Key offerings
Exhibits157: Merck and Co. Inc. – Overview
Exhibits158: Merck and Co. Inc. – Business segments
Exhibits159: Merck and Co. Inc. – Key news
Exhibits160: Merck and Co. Inc. – Key offerings
Exhibits161: Merck and Co. Inc. – Segment focus
Exhibits162: Novartis AG – Overview
Exhibits163: Novartis AG – Business segments
Exhibits164: Novartis AG – Key offerings
Exhibits165: Novartis AG – Segment focus
Exhibits166: Otsuka Holdings Co. Ltd. – Overview
Exhibits167: Otsuka Holdings Co. Ltd. – Business segments
Exhibits168: Otsuka Holdings Co. Ltd. – Key offerings
Exhibits169: Otsuka Holdings Co. Ltd. – Segment focus
Exhibits170: Pfizer Inc. – Overview
Exhibits171: Pfizer Inc. – Product / Service
Exhibits172: Pfizer Inc. – Key news
Exhibits173: Pfizer Inc. – Key offerings
Exhibits174: Sanofi – Overview
Exhibits175: Sanofi – Business segments
Exhibits176: Sanofi – Key news
Exhibits177: Sanofi – Key offerings
Exhibits178: Sanofi – Segment focus
Exhibits179: Takeda Pharmaceutical Co. Ltd. – Overview
Exhibits180: Takeda Pharmaceutical Co. Ltd. – Product / Service
Exhibits181: Takeda Pharmaceutical Co. Ltd. – Key news
Exhibits182: Takeda Pharmaceutical Co. Ltd. – Key offerings
Exhibits183: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits184: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits185: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits186: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits187: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits188: Viatris Inc. – Overview
Exhibits189: Viatris Inc. – Business segments
Exhibits190: Viatris Inc. – Key news
Exhibits191: Viatris Inc. – Key offerings
Exhibits192: Viatris Inc. – Segment focus
Exhibits193: Inclusions checklist
Exhibits194: Exclusions checklist
Exhibits195: Currency conversion rates for US$
Exhibits196: Research methodology
Exhibits197: Validation techniques employed for market sizing
Exhibits198: Information sources
Exhibits199: List of abbreviations